We are pleased to announce that 2 more hospital sites have opened to recruitment for Octopus. Anne Rowling Regenerative Neurology clinic in Edinburgh and University hospital Southampton. Congratulations to both teams for joining Octopus. For the Anne Rowling Regenerative Neurology clinic, the news was announced on their website. Please also see their Twitter account for al ...
Trial news
Octopus trial featured on the BBC
The BBC reported today on the opening of the Octopus trial to recruitment at the Queen Square Centre for MS, National Hospital for Neurology and Neurosurgery in London. It was covered on the BBC News (article). Further information is available at the MRC CTU at UCL website. . ...
Patient involvement in the design of the Octopus trial and selection of treatments recognised at international conference on trials in MS
This post was authored by Susan Scott, Octopus PPI (Patient and Public Involvement) Representative, member of the Trial Management Group, and Co-Applicant on the grant that funded the trial. It was originally published in the MS Society's North Herts newsletter. Two of us patient representatives on the Octopus trial were very honoured to fly to Toronto in December to an Intern ...
Next step for Octopus!
Octopus has now received the approvals needed for the trial to proceed. These are from the Health Research Authority (HRA), Medicines and Healthcare products Regulatory Agency (MHRA) and the Research Ethics Committee (REC). The chosen treatments are Metformin and R/S Alpha Lipoic Acid. Further details are available via the MS Society. The next steps are now to work with ...
MS at the Limits
Octopus featured at a recent educational event on multiple sclerosis. Prof Jeremy Chataway, the Chief Investigator for the trial, spoke to an audience of other MS professionals about the need for new treatments that slow down progressive MS, and how Octopus seeks to address that need. The talk took place at the MS at the Limits event at the end of September this year, and an ...
